发明名称 |
Vaccine composition comprising an antigen and a peptide having adjuvant properties |
摘要 |
The invention relates to a vaccine which comprises at least one antigen and a peptide comprising a sequence R1—XZXZNXZX—R2, whereby N is a whole number between 3 and 7, preferably 5, X is a positively charged natural and/or non-natural amino acid residue, Z is an amino acid residue selected from the group consisting of L, V, I, F and/or W, and R1 and R2 are selected independently one from the other from the group consisting of —H, —NH2, —COCH3, —COH, a peptide with up to 20 amino acid residues or a peptide reactive group or a peptide linker with or without a peptide; X—R2 may also be an amide, ester or thioester of the C-terminal amino acid residue, as well as the use of said peptide for enhancing a patient's adaptive immune response to an antigen. |
申请公布号 |
US8900564(B2) |
申请公布日期 |
2014.12.02 |
申请号 |
US200812124785 |
申请日期 |
2008.05.21 |
申请人 |
Valneva Austria GmbH |
发明人 |
Fritz Jörg;Mattner Frank;Zauner Wolfgang;Nagy Eszter;Buschle Michael |
分类号 |
A61K38/00;A61K38/04;A61K38/08;A61K38/27;A61K39/00;A61K45/00;A61K48/00;C07K7/06;A61K39/39;C07K4/00 |
主分类号 |
A61K38/00 |
代理机构 |
Wolf, Greenfield & Sacks, P.C. |
代理人 |
Wolf, Greenfield & Sacks, P.C. |
主权项 |
1. A method of enhancing a patient's adaptive immune response to an antigen comprising:
obtaining at least one antigen; obtaining at least one peptide comprising a sequence H-KLKLLLLLKLK-H (SEQ ID NO:1; and administering the antigen and the peptide to a patient. |
地址 |
Vienna AT |